These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27840964)

  • 1. miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5‑fluorouracil by targeting EIF4E.
    Yang X; Zang J; Pan X; Yin J; Xiang Q; Yu J; Gan R; Lei X
    Oncol Rep; 2017 Jan; 37(1):563-570. PubMed ID: 27840964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.
    Zhang Y; Tie Q; Bao Z; Shao Z; Zhang L
    Comput Math Methods Med; 2021; 2021():6468405. PubMed ID: 34812269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
    Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
    Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
    Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
    Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X; Qin J; Lu S
    Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
    Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
    Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
    BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
    Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
    Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
    Wang P; Zhuang C; Huang D; Xu K
    Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
    Zhang JJ; Wang CY; Hua L; Yao KH; Chen JT; Hu JH
    Int J Clin Exp Pathol; 2015; 8(5):5168-74. PubMed ID: 26191213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.